During the past decade, Centro de Investigacion del Maule conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 6 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 6 clinical trials were completed. i.e. 85.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centro de Investigacion del Maule" #1 sponsor was "Boehringer Ingelheim" with 5 trials, followed by "Janssen Vaccines & Prevention B.V." with 2 trials sponsored, "Galapagos NV" with 1 trials sponsored, "Genentech, Inc." with 1 trials sponsored and "Horizon Therapeutics Ireland DAC" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centro de Investigacion del Maule" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Centro de Investigacion del Maule" are "Idiopathic Pulmonary Fibrosis" (3 trials), "Lung Diseases, Interstitial" (3 trials), "Chronic Obstructive Pulmonary Disease" (1 trials), "Crohn's Disease" (1 trials) and "Influenza A" (1 trials). Many other conditions were trialed in "Centro de Investigacion del Maule" in a lesser frequency.

Most popular intervention types in "Centro de Investigacion del Maule" are "Drug" (10 trials), "Biological" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Nintedanib" (4 trials), "Ad26.COV2.S" (1 trials), "Adenovirus serotype 26 (Ad26)-based respiratory syncytial virus (RSV). preF" (1 trials) and "Astegolimab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centro de Investigacion del Maule" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Centro de Investigacion del Maule". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Centro de Investigacion del Maule, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Centro de Investigacion del Maule, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".